NCT00499473View on ClinicalTrials.gov

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

October 31, 2014

Conditions
Adult Anaplastic AstrocytomaAdult Diffuse AstrocytomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaAdult Mixed GliomaAdult OligodendrogliomaAdult Pineal Gland Astrocytoma
Interventions
DRUG

sunitinib malate

Given orally

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00499473 - Sunitinib in Treating Patients With Recurrent Malignant Gliomas | Biotech Hunter | Biotech Hunter